Resveratrol promotes foot ulcer size reduction in type 2 diabetes patients.

Bashmakov, Yuriy K; Assaad-Khalil, Samir H; Abou Seif, Myriam; Udumyan, Ruzan; Megallaa, Magdy; Rohoma, Kamel H; Zeitoun, Mohamed; Petyaev, Ivan M

Bashmakov, Yuriy K; Assaad-Khalil, Samir H; Abou Seif, Myriam; Udumyan, Ruzan; Megallaa, Magdy; Rohoma, Kamel H; Zeitoun, Mohamed; Petyaev, Ivan M.

Afiliación

Bashmakov YK; Lycotec Ltd, Granta Park, Platinum Building, Cambridge CB21 6GP, UK.
Assaad-Khalil SH; Department of Internal Medicine, Faculty of Medicine, Alexandria University, Alexandria 21527, Egypt.
Abou Seif M; Department of Clinical Pathology, Faculty of Medicine, Alexandria University, Alexandria 21527, Egypt.
Udumyan R; Clinical Epidemiology and Biostatistics, Örebro University Hospital and School of Health and Medical Sciences, Örebro University, Örebro, Sweden.
Megallaa M; Department of Internal Medicine, Faculty of Medicine, Alexandria University, Alexandria 21527, Egypt.
Rohoma KH; Department of Internal Medicine, Faculty of Medicine, Alexandria University, Alexandria 21527, Egypt.
Zeitoun M; Department of Internal Medicine, Faculty of Medicine, Alexandria University, Alexandria 21527, Egypt.
Petyaev IM; Lycotec Ltd, Granta Park, Platinum Building, Cambridge CB21 6GP, UK.

ISRN Endocrinol ; 2014: 816307, 2014.

Article en En | MEDLINE | ID: mdl-24701359

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: ISRN Endocrinol Año: 2014 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google